-
11.
公开(公告)号:US12071627B2
公开(公告)日:2024-08-27
申请号:US18458752
申请日:2023-08-30
申请人: Akouos, Inc.
IPC分类号: C12N15/86 , A01K67/0276 , A61K38/17 , A61K48/00 , A61P27/16 , C07K14/47 , C12N5/0793 , C12N9/16 , C12N15/52 , C12N15/65 , C12N15/90
CPC分类号: C12N15/52 , A01K67/0276 , A61K38/1709 , A61K48/0075 , A61P27/16 , C07K14/47 , C12N5/062 , C12N9/16 , C12N15/65 , C12N15/86 , C12N15/902 , A01K2217/075 , A01K2227/103 , A01K2267/03 , C12N2310/20 , C12N2750/14143 , C12N2830/008 , C12Y301/03001
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
-
12.
公开(公告)号:US11993777B2
公开(公告)日:2024-05-28
申请号:US18458744
申请日:2023-08-30
申请人: Akouos, Inc.
IPC分类号: C12N15/52 , A01K67/027 , A01K67/0276 , A61K38/17 , A61K48/00 , A61P27/16 , C07K14/47 , C12N5/0793 , C12N9/16 , C12N15/65 , C12N15/86 , C12N15/90
CPC分类号: C12N15/52 , A01K67/0276 , A61K38/1709 , A61K48/0075 , A61P27/16 , C07K14/47 , C12N5/062 , C12N9/16 , C12N15/65 , C12N15/86 , C12N15/902 , A01K2217/075 , A01K2227/103 , A01K2267/03 , C12N2310/20 , C12N2750/14143 , C12N2830/008 , C12Y301/03001
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
-
13.
公开(公告)号:US20230407315A1
公开(公告)日:2023-12-21
申请号:US18458744
申请日:2023-08-30
申请人: Akouos, Inc.
IPC分类号: C12N15/52 , A01K67/027 , C12N15/65 , A61K48/00 , C07K14/47 , A61P27/16 , A61K38/17 , C12N5/0793 , C12N9/16 , C12N15/86 , C12N15/90
CPC分类号: C12N15/52 , A01K67/0276 , C12N15/65 , A61K48/0075 , C07K14/47 , A61P27/16 , A61K38/1709 , C12N5/062 , C12N9/16 , C12N15/86 , C12N15/902 , C12N2750/14143 , C12N2310/20 , C12N2830/008 , A01K2267/03 , A01K2217/075 , A01K2227/103 , C12Y301/03001
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
-
公开(公告)号:US20230201372A1
公开(公告)日:2023-06-29
申请号:US17924933
申请日:2021-05-12
发明人: Emmanuel John Simons , Robert Ng , Yen-Fu Cheng
IPC分类号: A61K48/00 , A61K38/17 , C07K14/705 , C12N15/86 , A61P27/16
CPC分类号: A61K48/005 , A61K38/1709 , C07K14/705 , C12N15/86 , A61P27/16 , A61K48/0075 , C12N2750/14143
摘要: The present disclosure provides constructs comprising a coding sequence operably linked to a promoter, wherein the coding sequence encodes a pendrin protein. Exemplary constructs include AAV constructs. Also provided are methods of using disclosed constructs for the treatment of hearing loss and/or deafness.
-
公开(公告)号:US20220267739A1
公开(公告)日:2022-08-25
申请号:US17697099
申请日:2022-03-17
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng , Michael McKenna
摘要: Provided herein are methods that include introducing into an inner ear of a mammal a therapeutically effective amount of an adeno-associated virus (AAV) vector that includes a nucleotide sequence encoding (a) a polypeptide including an antibody heavy chain variable domain operably linked to a signal peptide and a polypeptide including an antibody light chain variable domain operably linked to a signal peptide; (b) a polypeptide including an antigen-binding antibody fragment operably linked to a signal peptide; or (c) a soluble vascular endothelial growth factor receptor operably linked to a signal peptide.
-
公开(公告)号:US20210330814A1
公开(公告)日:2021-10-28
申请号:US17259661
申请日:2019-07-12
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of a stereocilin protein, and the use of these compositions to treat non-syndromic sensorineural hearing loss in a subject.
-
17.
公开(公告)号:US12077773B2
公开(公告)日:2024-09-03
申请号:US18485178
申请日:2023-10-11
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng
CPC分类号: C12N15/86 , A61P27/16 , C07K14/47 , A61K48/00 , C12N2750/14143 , C12N2750/14144
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
-
18.
公开(公告)号:US20240139344A1
公开(公告)日:2024-05-02
申请号:US18269307
申请日:2021-12-22
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng
IPC分类号: A61K48/00 , C07K14/705 , C12N15/86
CPC分类号: A61K48/0058 , A61K48/0075 , A61K48/0091 , C07K14/705 , C12N15/86 , C12N2750/14122 , C12N2750/14143 , C12N2750/14152 , C12N2830/008 , C12N2830/42 , C12N2830/50 , C12N2840/445
摘要: The present disclosure provides constructs comprising a coding sequence operably linked to a promoter, wherein the coding sequence encodes a clarin 1 protein. Exemplary constructs include AAV constructs. Also provided are methods of using disclosed constructs for the treatment of hearing loss and/or deafness. Also provided are methods of using disclosed constructs for the treatment of vision loss.
-
19.
公开(公告)号:US11807867B2
公开(公告)日:2023-11-07
申请号:US17816305
申请日:2022-07-29
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng
CPC分类号: C12N15/86 , A61P27/16 , C07K14/47 , A61K48/00 , C12N2750/14143 , C12N2750/14144
摘要: Provided herein are compositions that include at least two different nucleic acid vectors, where each of the at least two different vectors includes a coding sequence that encodes a different portion of an otoferlin protein, and the use of these compositions to treat hearing loss in a subject.
-
20.
公开(公告)号:US20230295287A1
公开(公告)日:2023-09-21
申请号:US18134095
申请日:2023-04-13
申请人: Akouos, Inc.
发明人: Emmanuel John Simons , Robert Ng , Michael McKenna
CPC分类号: C07K16/22 , C12N15/86 , C07K14/55 , C07K14/005 , A61K48/0066 , A61P27/16 , C12N2750/14143 , C12N2750/14152 , C07K2317/55 , C07K2317/24 , C07K2317/76
摘要: The present disclosure provides a construct comprising a coding sequence operably linked to a promoter, wherein the coding sequence encodes a vascular endothelial growth factor (VEGF) binding agent or a portion thereof. In some embodiments, a construct is an AAV construct. In some embodiments, an AAV construct is a part of an AAV particle. Compositions comprising constructs and AAV particles described herein can be useful in treating hearing loss, for example, hearing loss associated with vestibular schwannoma.
-
-
-
-
-
-
-
-
-